Peripheral Nerve Stimulation Didactic & Cadaver Workshop

Washington, D.C.

May 18-19, 2019

$1,500.00

ONLY 11 POSITIONS REMAIN AVAILABLE

WAPMU Peripheral Nerve Stimulation Didactic and Cadaver Workshop

May 18-19, 2019

Time: 8:00am-5:00pm both days

Embassy Suites by Hilton Crystal City National Airport

1300 Jefferson Davis Highway

Arlington, VA 22202

Link to book Hotel- CLICK HERE

Residents and Fellows

 

WAPMU provides the opportunity for Residents or Fellows to register for meetings and workshops of WAPMU at a substantial discount. For more information please click here.

 

Target audience 

 

Anesthesiology, Pain Medicine, Physical Medicine and Rehabilitation, Neurology, Neurological Surgery, Orthopedic surgery, Radiology.

Outline

The course is designed to provide detailed knowledge of peripheral nerve anatomy and hands-on training of PNS implants. All new technology will be presented.

 

Learning Objectives

 

•Peripheral Nerve Stimulation Overview Focused on Anatomy and Mechanisms of Action

•History and Lessons Learned

•Peripheral nerve injuries and its diagnosis. Correlation between MRI and ultrasound.

•Controversies in Peripheral Nerve Stimulation

•Peripheral Nerve Stimulation Best Practices

•Peripheral Nerve Stimulation Case Studies Panel Discussion

•Ultrasound of PNS Targets (live model): participants will practice individually to achieve necessary competence

•Implantation Technique (cadaver): participants will be instructed to perform implantations  

Demonstrate and Train the Following Peripheral Nerve Implant Location Techniques

Ulnar, Median, Radial, Supra scapular, Axillary, Intercostal, Ilioinguinal, Lateral femoral cutaneous, Pudendal, Saphenous, Tibial, Sural, Superficial peroneal, Common peroneal, Sciatic, Femoral, Occipital , Genicular, Cluneal

 

Invited Faculty

Amitabh Gulati, M.D., Memorial Sloan Kettering Cancer Center

Mark Friedrich Hurdle, Mayo Clinic, Jacksonville, USA

Sadiq Bhayani, M.D., University Hospitals Leicester, United Kingdom

David Spinner, D.O.,  Icahn School of Medicine at Mount Sinai

Mike Mizrahi, D.O., Weill Cornell Medical Center

Eric H. Williams, M.D., The Dellen Institute

Jennifer Hah, M.D., Stanford University School of Medicine

Neal Rekesh, M.D., New York- Presbyterian Hospital

Rahul Bhansali, M.D., Circle Nottingham NHS Trust Treatment Centre, United Kingdom

Matthew Pingree, M.D., Mayo Clinic, Rochester, USA

Priyanka Ghosh, M.D., Weill Cornell, Hospital for Special Surgery and Memorial Sloan Kettering Cancer Center

Ehtesham Baig, M.D., Toronto Western Hospital

 
 

Corporate Partners

 
 
 

This activity is jointly sponsored by Dannemiller and the WAPMU. This activity has been planned and implemented by Dannemiller and WAPMU. In support of improving patient care, Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Dannemiller designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

AMA Designation of Credits: Dannemiller designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ADA statement: Dannemiller and the WAPMU fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Scot Sarver at ssarver@wapmu.org by May 1, 2019 to receive service.

 

Faculty Disclosure: As a provider accredited by ACCME, Dannemiller must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.